ADA 2023. Results from PIONEER PLUS trial showed oral semaglutide 25 mg and 50 mg were superior than 14 mg in reducing HbA1c and body weight in adults with T2D.
Sydney Jennings
Advertisement
Sydney Jennings is the editor of Patient Care Online. She joined MJH Life Sciences in March 2018 after graduating from the University of Connecticut with a BA in Journalism. She can be reached at [email protected].
Articles by Sydney Jennings
Your daily dose of clinical news you may have missed.
ADA 2023. Once-daily oral semaglutide 50 mg induced 15.1% weight loss in adults with overweight or obesity without type 2 diabetes vs placebo.
Your daily dose of clinical news you may have missed.
Early intervention is important to reduce the risk for complications for patients with obesity and type 2 diabetes. Two obesity experts explain more, here.
Your daily dose of clinical news you may have missed.
Your daily dose of clinical news you may have missed.
Listen to 2 obesity experts discuss and analyze the role of insulin resistance in type 2 diabetes and obesity.
Your daily dose of clinical news you may have missed.
ENDO 2023. Women with PCOS face an increased risk of mortality, particularly death due to cardiovascular disease and diabetes, compared with those without PCOS.
Your daily dose of clinical news you may have missed.
Your daily dose of clinical news you may have missed.
Your daily dose of clinical news you may have missed.
Finerenone was associated with a decrease in composite CV risk in patients with CKD, T2D, eGFR of ≥25, and moderately to severely increased albuminuria.
Your daily dose of clinical news you may have missed.
Your daily dose of clinical news you may have missed.
Patients with diabetes had a 35% higher risk of COPD compared with those without diabetes, according to new research.
More research is needed to determine whether metformin is also effective in patients with lower body mass index or with previous infection, said researchers.
Your daily dose of clinical news you may have missed.
A new data brief from the NCHS examined the characteristics of US adults who did not take medication as prescribed to reduce costs. A breakdown of the results, here.
Children hospitalized for RSV with LRTI during infancy have increased symptoms and lung function abnormalities, including increased resistance and decreased compliance.
Medical director of the NFID William Schaffner, MD, shares 3 things about the RSV vaccine that should be top of mind for primary care clinicians.
Your daily dose of clinical news you may have missed.
Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.
Your daily dose of clinical news you may have missed.
In a new study of adults with T2D and/or HF, those with higher prescription copayments were less likely to achieve 1-year adherence to GLP1-RA and SGLT2i therapies.
After an acute myocardial infarction, adults with diabetes were over 50% more likely to die after 1 year than those without diabetes, a new study shows.
Your daily dose of clinical news you may have missed.
Researchers found a total of 12 symptoms that contributed to the long COVID scoring system.
Delivering 3 vaccines to older adults is going to be a challenge this fall, says Dr William Schaffner.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Newer GLP-1 Therapies Linked to Fewer Alcohol-Related Hospitalizations in Adults With AUD
2
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
3
Compulsive Smartphone Use Linked to Depressive Symptoms in Older Adults
4
Early Liver Disease Detection Starts in Primary Care: A Q&A With Stevan Gonzalez, MD
5